Switch to:

Endocyte Inc (ECYT) Ownership Data

Short Interest History (%)

This is the historical short interest of Endocyte Inc, as measured by the Short Percentage Of Float.

Date Short Interest
July 15, 201515.99
June 30, 201516.68
June 15, 201517.71
May 29, 201518.73
May 15, 201519.13
April 30, 201518.82
April 15, 201519.44
March 31, 201519.79
March 13, 201519.9
February 27, 201520.14
February 13, 201520.71
January 30, 201520.51
January 15, 201519.59
December 31, 201419.72
December 15, 201420.33
November 28, 201420.58
November 14, 201422.45
October 31, 201422.61
October 15, 201424.2
September 30, 201422.77
September 15, 201421.54
August 29, 201420.17
August 15, 201419.53
July 31, 201421.33
July 15, 201423.29
June 30, 201420.73
June 13, 201420.4
May 30, 201419.6
May 15, 201419.28
April 30, 201414.17
April 15, 201414.46
March 31, 201414.51
March 14, 201418.28
February 28, 201416.39
February 14, 201415.76
January 31, 201413.68
January 15, 201412.29
December 31, 201312.16
December 13, 201311.42
November 29, 201311.34
November 15, 201311.12
October 31, 201310.59
October 15, 201310.72
September 30, 20139.47
September 13, 20139.12
August 30, 20138.95
August 15, 20138.15
July 31, 20137.72
July 15, 20138.28
June 28, 20137.79
June 14, 20137.6
May 31, 20137.29
May 15, 20137.26
April 30, 20137.5
April 15, 20136.46
March 28, 20137.58
March 15, 20137.6
February 28, 20137.55
February 15, 20137.2
January 31, 20137.25
January 15, 20137.48
December 31, 20127.88
December 14, 20128.34
November 30, 20128.89
November 15, 20128.75
October 31, 20128.21
October 15, 20128.08
September 28, 20128.21
September 14, 20129.69
August 31, 201210.1
August 15, 201210.61
July 31, 201210.72
July 13, 201210.66
June 29, 201210.78
June 15, 20128.56
May 31, 20127.62
May 15, 20127.94
April 30, 20127.61
April 13, 20126.01
March 30, 20129.13
March 15, 20128.66
February 29, 20128.22
February 15, 20128.22
January 31, 20128.78
January 13, 20128.8
December 30, 20118.47
December 15, 20116.47
November 30, 20116.82
November 15, 20114.87
October 31, 20115.2
October 14, 20115.62
September 30, 20115.18
September 15, 20115.34
August 31, 20114.23
August 15, 20113.59
July 29, 20114.24
July 15, 20113.61
June 30, 20114.22
June 15, 20113.19
May 31, 20112.96
May 13, 20113.03
April 29, 20113.09
April 15, 20112.8
March 31, 20110.24
March 15, 20110.03
February 28, 20110.1
February 15, 20110.02

Institutional Ownership History (%)

This the Institutional Ownership History of Endocyte IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
June 30, 201544
March 31, 201544
December 31, 201441
September 30, 201442
June 30, 201453
March 31, 201470
December 31, 201356
September 30, 201354
June 30, 201346
March 31, 201342
December 31, 201243
September 30, 201242
June 30, 201245
March 31, 201240
December 31, 201153
September 30, 201152
June 30, 201142
March 31, 201143

Insider ownership (%)

This is the historical insider ownership of Endocyte Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20153
March 31, 20153
February 28, 20153
January 31, 20152
December 31, 20142
November 30, 20142
October 31, 20142
September 30, 20142
August 31, 20142
July 31, 20142
June 30, 20142
May 31, 20142
March 31, 20142
February 28, 20142
January 31, 20142
December 31, 20132
November 30, 20132
October 31, 20132
September 30, 20132
August 31, 20132
July 31, 20132
June 30, 20132
May 31, 20132
April 30, 20132
March 31, 20132
January 31, 20132
November 30, 20122
October 31, 20122
September 30, 20122
August 31, 20123
July 31, 20123
June 30, 20123
May 31, 20123
April 30, 20123
March 31, 20123
February 29, 20123
January 31, 20123
December 31, 20113
November 30, 20112
October 31, 20112
September 30, 20112
August 31, 20112
July 31, 20112
June 30, 20112
May 31, 20112
April 30, 20112
March 31, 20112
February 28, 20112

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. P. Ron EllisPresident and CEO305,1960.73%2015-02-06
Douglas G. BaileyDirector198,2970.47%2011-12-16
Dr. Philip S. Low, PhDChief Science Officer198,1090.47%2015-02-10
Fred A. MiddletonDirector170,9990.41%2015-05-14
Mr. Michael A. ShermanCFO110,9090.26%2015-02-04
Dr. Christopher P. Leamon, PhDVice President of Research39,8550.1%2015-02-10
Dr. Allen R. Ritter, PhDVP of Manufacturing/CMC34,282less than 0.1%2014-04-09
Dr. Binh Nguyen, M.D.,PhDVP of Medical Affairs28,359less than 0.1%2015-03-03
John C. Aplin,PhDDirector23,313less than 0.1%2015-05-14
Scot HarperN/A15,557less than 0.1%2015-02-04

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus4,921,7232015-03-3111.74N/A30,810
Fidelity® Growth Company Fund2,829,4152015-05-316.750.0417,175
BlackRock Fund Advisors   Premium Plus1,569,7682015-03-313.74N/A9,827
Vanguard Group, Inc.   Premium Plus1,077,2262015-03-312.57N/A6,743
Highland Capital Management L.P.   Premium Plus999,3152015-03-312.380.136,256
Pinnacle Associates, Inc.   Premium Plus996,7682015-03-312.380.126,240
Highland Long/Short Healthcare Fund979,3152015-03-312.341.276,131
Highland Capital Management Fund Advisors, L.P.979,3152015-03-312.341.276,131
Millennium Management LLC   Premium Plus809,6322015-03-311.930.015,068
Fidelity® Series Growth Company Fund753,1002015-05-311.800.044,571

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK